XML 51 R40.htm IDEA: XBRL DOCUMENT v3.21.2
Stockholders’ Equity (Details Narrative) - USD ($)
Oct. 14, 2021
Oct. 13, 2021
Dec. 31, 2021
Oct. 06, 2021
Sep. 30, 2021
Dec. 31, 2020
Subsidiary or Equity Method Investee [Line Items]            
Preferred stock, shares authorized         20,000,000 20,000,000
Preferred stock, par value         $ 0.001 $ 0.001
Preferred stock, shares issued         0 0
Preferred stock, shares outstanding         0 0
Common stock, shares authorized         100,000,000 100,000,000
Common stock, par value per share         $ 0.001 $ 0.001
Common Stock, Shares, Outstanding         14,114,707 14,114,707
Offering costs     $ 0   $ 0  
Subsequent Event [Member]            
Subsidiary or Equity Method Investee [Line Items]            
Common stock, shares authorized       100,000,000.0    
Subsequent Event [Member] | IPO [Member]            
Subsidiary or Equity Method Investee [Line Items]            
Stock issued during period, shares 5,000,000.0          
Sale of stock, price per share $ 14.00          
Proceeds from issuance of initial publoc offering $ 70,000,000.0          
Underwriting fees 4,900,000          
Offering costs $ 700,000          
Senior Notes [Member] | Subsequent Event [Member]            
Subsidiary or Equity Method Investee [Line Items]            
Debt conversion, shares issued upon conversion   15,803,200        
Debt conversion, original debt amount   $ 22,400,000        
PAVmed Inc. [Member]            
Subsidiary or Equity Method Investee [Line Items]            
Shares, Outstanding         11,552,562 11,552,562
Parent Company [Member] | Subsequent Event [Member] | IPO [Member]            
Subsidiary or Equity Method Investee [Line Items]            
Stock issued during period, shares 571,428